Skip to content
MarketScale
‹ Back to IndustriesHealthcare

Reimagining Patient Rooms in Smart Hospitals of the Future

The healthcare industry is undergoing dramatic changes thanks to rapid digitization and the adoption of AI. Nowhere are these changes more evident than in hospitals, where increased connectivity, data analysis at the edge, and patient monitoring are helping staff rethink patient care. In this episode of “Health and Life Sciences at the Edge,” host Daniel…

This story was produced through MarketScale. See how Healthcare teams put it to work with Executive Thought Leadership.

Promoted content from Intel on MarketScale.

Share

Get featured

Want to get featured in MarketScale Healthcare?

Create a free MarketScale workspace and get your company's expertise featured across our Healthcare coverage. No credit card, no demo required.

Request an invite

The healthcare industry is undergoing dramatic changes thanks to rapid digitization and the adoption of AI. Nowhere are these changes more evident than in hospitals, where increased connectivity, data analysis at the edge, and patient monitoring are helping staff rethink patient care. In this episode of “Health and Life Sciences at the Edge,” host Daniel Litman talks with Karen Perry, Intel’s Chief Healthcare IoT Solution Architect, and Lisbeth Votruba, Chief Clinical Innovation Officer at AvaSure, about how smart technologies can improve care, particularly when implemented in patient rooms.

Karen Perry, whose job is to look at all parts of the Smart Hospital puzzle, says “We have to work closely with clinicians to make sure that when we introduce a technology it’s something they can leverage.” Lisbeth Votruba agrees saying, “I believe we’ve reached an inflection point we’ve been heading towards for years. More and more nurses are considering leaving and more than 28% of new nurses will leave the profession within the first year.”

The good news, according to Votruba, is that there’s a new urgency and willingness to invest in smart solutions that support the workforce. “One of the big barriers to implementing forward thinking technology in hospitals is competing priorities,” says Votruba. “I’m seeing more and more leaders prioritizing technologies that help educate, retain, and make the work of new staff easier.”

Perry and Votruba are excited about the benefits of adding smart technologies to patient rooms, particularly computer vision and audio. However, Perry is quick to point out that the three metrics of success – positive outcomes for patients, the workforce, and the hospital – must be met. “As we introduce capabilities into hospitals, we have to create measurable goals,” she says. “Those three metrics are like the three legs of a tripod. We have to hit every one of them for hospitals to invest.”

Looking to the future, Perry and Votruba see the use of smart technologies as a journey. “What can happen next,” says Perry, “is we follow patients on their journeys through the system. That will allow us to create a more connected, cohesive, and effective healthcare system.”

I’m very hopeful,” says Votruba. “I’m not afraid of technology. I’ve seen the benefits and believe that the investment we’re making in technology will improve both the care patients receive and the humanity of how it’s delivered. Hopefully smart tech will let caregivers get back to the joy of why they chose this profession.”

Connect with Karen Perry and Lisbeth Votruba on LinkedIn or visit:

Subscribe to this channel on Apple Podcasts, Spotify, or Google Podcasts to hear more from the Intel Internet of Things Group.

Intel

Part of this channel

Intel

Silicon and AI platforms powering enterprise and edge compute.

Visit the channel

Your experts belong here

Every story in MarketScale Healthcare starts with a company putting its clinicians, service-line leaders, and field engineers on the record. Buyers are already reading this topic. The only question is whose experts they find.

Service-line buyers vet vendors quietly, and your clinicians become the proof they find while doing it.

Get your team featuredSee how it works15 minutes, straight to a calendar.

Follow Healthcare Insights

Get new expert content in your inbox.

Healthcare: are you visible to AI?

Before they reach out, Healthcare buyers ask AI engines which vendors to trust. See how AI describes your company today, and where competitors show up instead.

Free workspace

You just read one Healthcare expert. Your company is full of them.

This article was produced through MarketScale. The same platform turns your clinicians, service-line leaders, and field engineers into the articles, video, and social content Healthcare buyers are searching for. Create a free workspace and see it with your own people. No credit card, no demo required.

NPS +73 · 1,000+ creators · 38+ countries

What you get, free

Your own MarketScale Studio workspace
One video edit a month, on us
AI writing, editing, and publishing tools
In-platform coaching to learn the system

More Healthcare Insights

Tarsus’ $450M Alkeus deal puts phase 3 retina programs on the same integration plan

Tarsus’ $450M Alkeus deal puts phase 3 retina programs on the same integration plan

Tarsus has made a $450 million deal with Alkeus to acquire two assets, including a phase 3 oral Stargardt program and a post-injection antiseptic. The focus now moves to clinical trial operations, chemistry manufacturing and controls, and plans for specialty distribution. These acquisitions aim to expand Tarsus' retina programs.

  • 01Tarsus acquired a phase 3 oral Stargardt asset and a post-injection antiseptic for $450 million.
  • 02The acquisitions focus on enhancing clinical trial operations and chemistry manufacturing controls.
  • 03Plans for future specialty distribution of the acquired assets are in place.

Aug 29, 2026

FDA’s Oct. 19 AI docket forces medtech teams to write tests, not slide decks

FDA’s Oct. 19 AI docket forces medtech teams to write tests, not slide decks

The FDA has released a generative AI discussion paper proposing a shift towards competency-style evaluation and increased postmarket monitoring in the healthcare industry. This move may lead vendors and hospital buyers to prioritize developing robust testing protocols for AI applications. The focus is on ensuring reliable and safe AI implementation in medical technologies.

  • 01The FDA's discussion paper suggests implementing competency-style evaluation for AI in healthcare.
  • 02There is an emphasis on increased postmarket monitoring for AI applications in the medical field.
  • 03Vendors and hospital buyers are encouraged to focus on developing testing protocols rather than presentations.

Aug 29, 2026

SILMO Paris 2026 brings smart glasses and AI into the purchasing cycle

SILMO Paris 2026 brings smart glasses and AI into the purchasing cycle

SILMO Paris 2026 is focusing on integrating smart glasses and AI into the purchasing processes for optical retailers and labs. The event is anticipated to attract around 34,000 visitors and feature 950 exhibitors, indicating significant interest in AI imaging workflows and smart-glass innovations. The agenda highlights a future direction towards advanced technology in optical retail and laboratory settings.

  • 01SILMO Paris 2026 will host nearly 34,000 visitors and 950 exhibitors.
  • 02The event focuses on AI imaging workflows and smart-glass innovations for optical retailers and labs.
  • 03Significant interest is shown in integrating advanced technology within optical retail processes.

Aug 29, 2026

Explore More Healthcare Insights

Read more expert perspectives from across Healthcare.

Browse Healthcare Hub

For B2B teams

Your experts could be publishing here

Stories like this one run on content MarketScale captures from real practitioners. See how your team's expertise becomes coverage in Healthcare and beyond.

Book a 15-minute demo

Or call us. No forms required. We pick up. 214-945-2512